Click to rate this post!
[Total: 0 Your Rating: 0]You must sign in to vote
Developed at Mass General Hospital and Harvard University, C-Reveal’s proprietary technology helps the body’s immune system to identify and kill cancer cells. The company’s patent-pending discovery will make it easier to find and treat tumors and is expected to improve the efficacy of treatments for a broad range of cancers.
Founded by Harvard scientists with previous exits in excess of $8 billion
Proprietary technology developed at Massachusetts General Hospital (MGH) and Harvard University
Experienced leadership team from AstraZeneca, MGH, Harvard Medical School, and Dana-Farber
$140 billion+ oncology market expected to reach more than $390 billion by 2027
This offering goes live next week. Reserve your shares now.